BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14745351)

  • 1. Conference report - apoptosis - a graceful death: highlights from the 2003 Annual Meeting of the American Association for Cancer Research; July 11-14, 2003; Washington, DC.
    Mariani SM
    MedGenMed; 2003 Oct; 5(4):4. PubMed ID: 14745351
    [No Abstract]   [Full Text] [Related]  

  • 2. [PTEN expression in endometrial cancer and the prognosis].
    Kanamori Y; Uegaki K; Kigawa J; Terakawa N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genetic abnormalities in endometrial cancer].
    Takeshima N; Hirai Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():254-8. PubMed ID: 15535246
    [No Abstract]   [Full Text] [Related]  

  • 4. [PTEN--a new tumor inhibitory gene].
    Tian X; Wu H
    Zhonghua Bing Li Xue Za Zhi; 2000 Dec; 29(6):455-7. PubMed ID: 12790140
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression activity of pro-apoptotic gene products in cancer cells, a potential application for cancer gene therapy.
    Lin J; Page C; Jin X; Sethi AO; Patel R; Nunez G
    Anticancer Res; 2001; 21(2A):831-9. PubMed ID: 11396172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.
    Chakraborty M; Qiu SG; Vasudevan KM; Rangnekar VM
    Cancer Res; 2001 Oct; 61(19):7255-63. PubMed ID: 11585763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topics on gene abnormality in endometrial cancer].
    Shiozawa T; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():259-63. PubMed ID: 15535247
    [No Abstract]   [Full Text] [Related]  

  • 8. PTEN expression in melanoma: relationship with patient survival, Bcl-2 expression, and proliferation.
    Mikhail M; Velazquez E; Shapiro R; Berman R; Pavlick A; Sorhaindo L; Spira J; Mir C; Panageas KS; Polsky D; Osman I
    Clin Cancer Res; 2005 Jul; 11(14):5153-7. PubMed ID: 16033830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in prostate cancer: progressive and therapeutic implications (Review).
    Wang G; Reed E; Li QQ
    Int J Mol Med; 2004 Jul; 14(1):23-34. PubMed ID: 15202013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
    Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C
    Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.
    Matsushima-Nishiu M; Unoki M; Ono K; Tsunoda T; Minaguchi T; Kuramoto H; Nishida M; Satoh T; Tanaka T; Nakamura Y
    Cancer Res; 2001 May; 61(9):3741-9. PubMed ID: 11325847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology and clinical relevance of the PTEN tumor suppressor pathway.
    Sansal I; Sellers WR
    J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and melanoma chemoresistance.
    Soengas MS; Lowe SW
    Oncogene; 2003 May; 22(20):3138-51. PubMed ID: 12789290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells.
    Zhu X; Kwon CH; Schlosshauer PW; Ellenson LH; Baker SJ
    Cancer Res; 2001 Jun; 61(11):4569-75. PubMed ID: 11389092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene.
    Tolkacheva T; Chan AM
    Oncogene; 2000 Feb; 19(5):680-9. PubMed ID: 10698513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation.
    Suzuki A; Itami S; Ohishi M; Hamada K; Inoue T; Komazawa N; Senoo H; Sasaki T; Takeda J; Manabe M; Mak TW; Nakano T
    Cancer Res; 2003 Feb; 63(3):674-81. PubMed ID: 12566313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PTEN tumor suppressor: functions as a lipid phosphatase].
    Maehama T; Dixon JE
    Tanpakushitsu Kakusan Koso; 2000 Oct; 45(14):2405-14. PubMed ID: 11051842
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
    Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
    Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer.
    Hirai Y; Tanaka N; Furuta R; Kawaguchi T; Sakamoto M; Shirahama S; Noda T
    Gynecol Oncol; 2001 Oct; 83(1):81-8. PubMed ID: 11585417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.